This inventor holds 37 USPTO granted patents and 7 EPO patents, primarily in Oligonucleotide Production. Top assignees: Ajinomoto Co., Ltd., Biogen Ma Inc.. Active years: 2002-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mie, JP (2013 - 2015)
- Yokkaichi, JP (2007 - 2021)
- Kawasaki, JP (2002 - 2024)
Company Filing History:


Years Active: 2002-2026
Areas of Expertise:
Title: Daisuke Takahashi: Pioneering Innovations in Peptide and Oligonucleotide Synthesis
Introduction: Daisuke Takahashi, a prominent inventor based in Yokkaichi, Japan, has made significant contributions to the fields of peptide and oligonucleotide synthesis. With a remarkable portfolio of 33 patents, his work continues to influence the landscape of biochemistry and pharmaceutical development.
Latest Patents: Among Daisuke's latest innovations are two notable patents. The first, titled "Method for producing cyclized peptide having intramolecular S-S bond," describes a method for preparing cyclized peptides characterized by one or more intramolecular S-S bonds. This advancement holds potential for various applications in drug development and therapeutics. The second patent, "Morpholino oligonucleotide manufacturing method," introduces an efficient liquid-phase synthesis approach. This method allows for the production of morpholino oligonucleotides in high yields by subjecting a reaction mixture to an extraction operation, subsequently separating the resultant morpholino oligonucleotide into the organic layer.
Career Highlights: Daisuke is currently associated with Ajinomoto Co., Ltd., a leading Japanese company known for its innovations in food products and biopharmaceuticals. His role at the company enables him to leverage his expertise in developing cutting-edge synthetic methodologies that push the boundaries of current biotechnological applications.
Collaborations: Throughout his career, Daisuke has collaborated with esteemed colleagues such as Kunisuke Izawa and Satoshi Katayama. These collaborations have fostered an environment of innovation and have contributed to the advancement of their respective research projects.
Conclusion: Daisuke Takahashi stands out as a visionary inventor whose patents are paving the way for new possibilities in peptide and oligonucleotide synthesis. His contributions not only exemplify his dedication to scientific innovation but also highlight the collaborative spirit essential in the field of research and development. As his career progresses, one can expect even more groundbreaking advancements from this talented inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile